Maryland Digital News > Blog > MARKET > GeoVax’s stock soars 43% to lead rally in companies developing mpox treatments MARKETGeoVax’s stock soars 43% to lead rally in companies developing mpox treatmentsMarylandDigitalNews.comMARKETposted on Aug. 19, 2024 at 3:25 pm A competing company’s mpox vaccine failed to meet its primary endpoint. Source link MarylandDigitalNews.comAugust 19, 2024previous articleIntel’s upcoming Arrow Lake desktop processors leaknext articleAmazon’s new Echo Spot drops to $55the authorMarylandDigitalNews.comYou Might Also LikeMARKETSean ‘Diddy’ Combs is selling $61.5 million Beverly Hills estate that was raided by FedsSeptember 17, 2024MARKETFanDuel owner Flutter Entertainment strikes $2.6 billion deal to buy Italy’s SnaitechSeptember 17, 2024MARKETYour financial adviser keeps calling. This is why you should call them back.September 17, 2024MARKETA Dish-DirecTV deal may not improve satellite TV’s fate much, but bonds still rallySeptember 17, 2024MARKETHow Microsoft’s dividend hike and new $60 billion buyback program stack upSeptember 16, 2024MARKETWhy Intel’s latest move for its foundry business is so significantSeptember 16, 2024
MARKETSean ‘Diddy’ Combs is selling $61.5 million Beverly Hills estate that was raided by FedsSeptember 17, 2024
MARKETFanDuel owner Flutter Entertainment strikes $2.6 billion deal to buy Italy’s SnaitechSeptember 17, 2024
MARKETA Dish-DirecTV deal may not improve satellite TV’s fate much, but bonds still rallySeptember 17, 2024
